Moscow City Health Department Report issue

Government Phase 3 Phase 4

Organization Overview

First Clinical Trial
2013
NCT01889433
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

City Clinical Hospital №24, Department of Health City of Moscow | Morozovskaya Children's City Clinical Hospital of the Moscow Department of Health | State Public Healthcare Institution of the City of Moscow Infectious Disease Clinical Hospital No. 1, Moscow City Health Department

Active Ingredients

Drugs in Phase 4 Trials (1)

incobotulinumtoxinA (Xeomin) (1 trial)

Drugs in Phase 3 Trials (3)

gam-covid-vac (rad26) (1 trial)

gam-covid-vac (rad5) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fissure in Ano (Phase 4)

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4